#USA #Digital Transformation #Milwaukee #Rockwell Automation #PharmaSuite

Rockwell Automation Unveils PharmaSuite 12.00

Rockwell Automation, a leader in industrial automation and digital transformation, has launched its latest version of the manufacturing execution system, FactoryTalk® PharmaSuite® 12.00. This innovative software is specifically designed to cater to the unique demands of the pharmaceutical and biopharmaceutical industries, enabling manufacturers to streamline operations and boost productivity.

Addressing Industry Challenges

In a sector facing the pressures of rapid development while maintaining compliance with stringent regulations, the demand for advanced solutions is paramount. Many manufacturers have reported that existing manufacturing execution systems (MES) are often costly and slow to implement. Recognizing these issues, Rockwell Automation has introduced PharmaSuite 12.00 to present a highly configurable, efficient, and forward-thinking platform.

The new release features a modular architecture and is cloud-ready, which allows companies more agility to adapt to the ever-evolving production requirements. Enhanced cybersecurity measures have also been integrated to help meet the rigorous compliance and data integrity demands typical within life sciences environments.

Key Features of PharmaSuite 12.00

PharmaSuite 12.00 boasts several notable enhancements that contribute to its effectiveness in the manufacturing landscape:

1. Cloud-Based Deployment: The system operates within Kubernetes, utilizing Linux containers that facilitate quicker and more dependable setup and maintenance processes.
2. New Setup Tool (MICKA): This tool automates installation and validation, significantly reducing the manual workload associated with regulated environments.
3. Modular Design: With containerized components, scaling operations across different sites becomes simpler and promotes standardized system deployments.
4. Built-in Monitoring: A centralized monitoring feature helps in early detection of issues, promoting faster troubleshooting.
5. Enhanced Cybersecurity: Developed using secure coding practices, the system adheres to industry standards to ensure data protection.
6. Simplified Upgrades: An upgraded engine keeps systems aligned with the latest features and security provisions efficiently.

By leveraging these advancements, PharmaSuite 12.00 is positioned to facilitate digital transformations within pharmaceutical production, enhancing performance, availability, and security simultaneously.

Supporting Manufacturers in Regulatory Compliance

Martin Petrick, the MES business manager at Rockwell Automation, emphasizes that this release is a significant advancement for life sciences manufacturers striving for modular and digital production methodologies while upholding the highest compliance standards.

“The flexibility to deploy in cloud environments, on-premises, or through hybrid models enables manufacturers to expedite operations efficiently. By simplifying global rollouts, PharmaSuite 12.00 reduces both time and costs associated with validation,” he stated.

In summary, FactoryTalk PharmaSuite 12.00 emerges as a critical tool for pharmaceutical and biopharmaceutical manufacturers seeking to navigate the complexities of modern production while adhering to regulatory obligations. The focus on scalability, rapid deployment, and enhanced digital solutions marks a transformative step forward for the industry.

For more information about FactoryTalk PharmaSuite, visit Rockwell Automation.

About Rockwell Automation

Rockwell Automation, Inc. (NYSE: ROK) remains a frontrunner in industrial automation and digital transformation, connecting the creative potentials of individuals with technological advancements to enhance productivity and foster sustainability worldwide. Headquartered in Milwaukee, Wisconsin, the company employs around 27,000 dedicated professionals across more than 100 countries as of 2024.